## Abstract ## Background Mounting evidence suggests that most tumors consist of a heterogeneous population of cells with a subset population that has the exclusive tumorigenic ability. They are called cancer stem cells (CSCs). CSCs can selfβrenew to generate additional CSCs and also differentiate
CD133, One of the Markers of Cancer Stem Cells in Hep-2 Cell Line
β Scribed by Liang Zhou; Xudong Wei; Lei Cheng; Jie Tian; Jack J. Jiang
- Book ID
- 110088383
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 441 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0023-852X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Hepatocellular carcinoma (HCC) is the third leading cause of cancer mortality worldwide. CD133, a transmembrane glycoprotein, is an important cell surface marker for both stem cells and cancer stem cells in various tissues including liver. CD133 expression has been recently linked to poor prognosis
## Dear Editor, We read the comments of Angela Gradilone et al. on our article ''Isolation and characterization of tumorigenic extrahepatic cholangiocarcinoma cells with stem cell-like properties.'' The authors concluded that CD133 and ALDH1 are two other molecular markers of putative cancer stem